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Although more and more children are born by Assisted Reproductive Technologies (ART), 33 
ART safety has not fully been demonstrated. Notably, ART could disturb the delicate step of 34 
implantation, and trigger placenta-related adverse outcomes with potential long-term effects, 35 
through disrupted epigenetic regulation. We have previously demonstrated that placental 36 
DNA methylation was significantly lower after IVF/ICSI than following natural conception at 37 
two differentially methylated regions (DMRs) associated with imprinted genes (IGs): 38 
H19/IGF2 and KCNQ1OT1. As histone modifications are critical for placental physiology, the 39 
aim of this study was to profile permissive and repressive histone marks in placenta biopsies 40 
to reveal a better understanding of the epigenetic changes in the context of ART. Utilizing 41 
chromatin immunoprecipitation (ChIP) coupled with quantitative PCR, permissive (H3K4me3, 42 
H3K4me2 and H3K9ac) and repressive (H3K9me3 and H3K9me2) post-translational histone 43 
modifications were quantified. The analyses revealed significantly higher quantity of 44 
H3K4me2 precipitation in the IVF/ICSI group than in the natural conception group for 45 
H19/IGF2 and KCNQ1OT1 DMRs (P = 0.016 and 0.003, respectively). Conversely, the 46 
quantity of both repressive marks at H19/IGF2 and SNURF DMRs was significantly lower in 47 
the IVF/ICSI group than in the natural conception group (P = 0.011 and 0.027 for H19/IGF2; 48 
and P = 0.010 and 0.035 for SNURF). These novel findings highlight that DNA 49 
hypomethylation at imprinted DMRs following ART is linked with increased 50 
permissive/decreased repressive histones marks, altogether promoting a more permissive 51 
chromatin conformation. This concomitant change in epigenetic state at IGs at birth might be 52 
an important developmental event because of ART manipulations. 53 
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It is estimated that more than six million children have been born by Assisted Reproductive 59 
Technologies (ART) worldwide, representing ~4% of all births [1,2]. However, the safety of 60 
these techniques has not fully been demonstrated. ART has been associated with an 61 
increased risk of placenta-related adverse pregnancy, perinatal outcomes and imprinting 62 
disorders [3-6]. As ART take place during the epigenetic-sensitive period of preimplantation 63 
when genome-wide erasure and selective reprogramming occur, these techniques could 64 
affect the implantation step, when the dialogue between endometrium and embryo 65 
establishes the placental invasion into the uterine wall [7]. Together, these data raise the 66 
concern of the potential epigenetic vulnerability associated with ART. 67 
Epigenetic mechanisms have been demonstrated to have a fundamental role in regulating 68 
placental function [7]. Notably, imprinted genes (IGs) are known to modulate foetal and 69 
placental growth, for example by regulating nutrients transfer, cell cycle and insulin 70 
metabolism [8-10]. Among imprinting mechanisms, DNA methylation in human placenta has 71 
been extensively studied, but literature about histone modifications after ART is relatively 72 
scarce. Modifications of basic histone amino (N)-terminal tail lead to changes in the overall 73 
chromatin structure and in the binding of effector molecules [11] and thus changes regulation 74 
of DNA transcription, replication, recombination and repair. For example, acetylation of the 75 
lysine 9 of histone H3 (H3K9ac) neutralizes the positive charge of histone H3, decreasing the 76 
histone’s affinity to bind DNA, resulting in a more “relaxed” chromatin state which is 77 
permissive to gene expression. More complex than acetylation, histone methylation can be 78 
either a permissive or a repressive mark, according to its location on the histone tail. Though 79 
tri-methylation of lysine 4 on histone H3 (H3K4me3) is permissive, tri-methylation of lysine 9 80 
on histone H3 is repressive when located in the promoters regions [12]. A wealth of data 81 
have underlined that histone modifications are critical for trophoblast establishment [13] and 82 
placental physiology [14]. Notably, chronic ischemia in the rodent placenta was linked to 83 
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decreased histone H3 acetylation levels [15]. In human, abnormal histone methylation at 84 
some imprinted DMRs was linked with the development of placental disorders such as 85 
preeclampsia and molar pregnancy [16]. Moreover, the interest of studying histone 86 
modifications in the context of ART is reinforced by the fact that histone marks could be 87 
disturbed by environmental stressors [17] and thus could mediate long-term health effects of 88 
ART. 89 
We previously demonstrated that DNA methylation in the placenta was significantly lower 90 
after IVF/ICSI than following natural conception at two imprinted DMRs: H19/IGF2 and 91 
KCNQ1OT1 [18]. The aim of this study was to determine whether DNA hypomethylation 92 
could be associated with specific histones profiles, to reveal a better understanding of the 93 
epigenetic modifications in the context of ART.  94 
 95 
 96 
Materials and methods 97 
 98 
Study population 99 
Patients were prospectively included from January 1st, 2013 to April 30th, 2015 in the 100 
Department of Obstetrics, Gynaecology and Reproductive Biology at Dijon University 101 
Hospital, France. “Natural conception” group included singleton pregnancies of women that 102 
had conceived spontaneously within 1 year after stopping contraception. “IVF/ICSI” group 103 
included singleton pregnancies achieved following fresh embryo transfer after two days of in 104 
vitro culture. This cohort has previously been described [18] and used to compare the DNA 105 
methylation, by pyrosequencing, of 51 IVF/ICSI vs. 48 placentas from natural conception for 106 
three imprinted DMRs associated with the H19/IGF2:IG-DMR, KCNQ1OT1:TSS-DMR, and 107 
SNURF:TSS-DMR, named according to the recommendations for nomenclature [19]. For the 108 
present study, to determine whether DNA hypomethylation could be associated with specific 109 
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histones profiles, 16 placentas from the IVF/ICSI group who presented with below 5th 110 
percentile for methylation for at least one of these DMRs were selected (Figure 1). They 111 
were compared with 16 controls matched for parity, new-born’s sex, and gestational age at 112 
delivery. The controls were selected among the 48 women with natural pregnancy from the 113 
previous study. 114 
 115 
Sample preparation  116 
Placenta samples (1 cm3) were extracted from the foetal side within 15 min after delivery, 117 
washed twice in 0.9% NaCl before being snap frozen in liquid nitrogen and conserved at -118 
80°C.  119 
 120 
DNA methylation and expression 121 
Data for expression and DNA methylation experiments were obtained from our previous 122 
publication using real-time PCR and pyrosequencing, respectively [18], and analysed on this 123 
new cohort of 32 samples. 124 
 125 
Histone modifications analyses by Chromatin ImmunoPrecipitation (ChIP) 126 
For the three imprinted DMRs previously analysed three permissive histone marks 127 
(di/trimethylation of lysine 4 of histone H3, H3K4me2/3; acetylation of lysine 9 of histone H3, 128 
H3K9ac) [20] and two repressive histone marks associated with heterochromatic states 129 
(di/trimethylation of lysine 9 of histone H3, H3K9me2/3) [21,22] were studied. 130 
 131 
Preparation of chromatin from placenta samples 132 
Approximately 2 grams of frozen placenta was rinsed two times in cold PBS and placed in 133 
lysis tubes (Zymo Research BashingBeads Lysis Tubes - 0.5 mm) containing 1 mL buffer I 134 
(0.5 M Tris-HCl pH 7.5, 0.5 M KCl, 2.5 M NaCl, 0.5 M MgCl2, 25 mM EGTA, 0.3 M sucrose, 135 
0.5 mM DTT, 0.1 mM PMSF, 3.6 ng/mL aprotinin, 5 mM sodium butyrate) and subject to 136 
three intervals of agitation (90 sec, 5000 rpm) using a Precellys24 homogenizer (Bertin 137 
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technologies) with 5 minutes on ice between each agitation cycle. The cell suspension was 138 
then placed in 7 mL of buffer II (buffer I with NP40 at a final concentration of 0.2%) to purify 139 
nuclei by centrifugation at 8500 rpm/12720g for 20 minutes with low acceleration and low 140 
deceleration on a sucrose gradient (8 mL from the previous step carefully placed on 25 mL of 141 
buffer III (0.5 M Tris-HCl pH 7.5, 0.5 M KCl, 2.5 M NaCl, 0.5 M MgCl2, 25 mM EGTA, 1.2 M 142 
sucrose, 0.5 mM DTT, 0.1 mM PMSF, 3.6 ng/mL aprotinin, 5 mM sodium butyrate) in 143 
SorvallTM RC 6 Plus Centrifuge (ThermoScientificTM). The nuclear pellet was resuspended in 144 
digestion buffer (0.32 M sucrose, 50 mM Tris-HCl pH 7.5, 4 mM MgCl2, 1mM CaCl2, 0.1 mM 145 
PMSF, 5mM sodium butyrate) to 0.4 mg DNA/mL (Quantification by absorbance). Aliquots of 146 
500 µL were distributed in 1.5 mL tubes. Micrococcal nuclease (Nuclease S7 15 IU/µL, 147 
Roche; final concentration 30 mIU/µL) was used to digest the chromatin to yield fragments 148 
one to five nucleosomes in length, which typically presented an incubation time of 3 minutes 149 
at 37°C. Digestion was stopped by adding 0.5 M EDTA at a final concentration of 20 mM and 150 
cooling on ice. After centrifugation (10 min, 15800g, 4°C), the supernatant was designated 151 
fraction S1. The pellet was resuspended in 500 µL lysis buffer (1 mM Tris-HCl pH 7.5, 0.2 152 
mM EDTA, 0.2 mM PMSF, 5 mM sodium butyrate) and left 20-30 minutes on ice and subject 153 
to a second centrifugation step (10 min, 15800g, 4°C), the supernatant of which was 154 
designated fraction S2. The size of the nucleosomes was determined following Nucleospin 155 
gel and PCR clean-up (Macherey-Nagel) of ~100 µL of each fraction, to ensure the S1 156 
chromatin fraction mainly comprised of mono and dinucleosomes and the S2 poly-157 
nucleosomes of 2 to 5 nucleosomes (Supplemental Figure 1).  158 
 159 
Immunoprecipitation of fresh chromatin 160 
For ChIP, we used antibodies directed against H3K4me3 (Diagenode C15410003-50), 161 
H3K4me2 (Millipore 07-030), H3K9ac (Cell Signaling 9649S), H3K9me3 (Abcam AB8898), 162 
H3K9me2 (Diagenode C15410060) and a negative control (mock precipitation with mouse 163 
IgG Millipore 12-371). 164 
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Chromatin was quantified by absorbance. For each condition, 4 µg of chromatin was used 165 
(constituted of 75% S1 and 25% S2) and suspended in incubation buffer (20 mM Tris-HCl pH 166 
7.5, 50 mM NaCl, 20 mM sodim butyrate, 5 mM EDTA, 0.1 mM PMSF) in a total volume of 167 
500 µL for each condition. We precleared chromatin by agitating overnight at 4°C with 4% 168 
Dynabeads ® Protein G for immunoprecipitation (Invitrogen) washed three times in PBS-BSA 169 
5%. In parallel, antibodies were combined to Dynabeads ® Protein G for immunoprecipitation 170 
(Invitrogen), each antibody being agitated overnight in 250 µL of PBS-BSA 5% containing 171 
16% of beads previously washed three times in PBS-BSA 5%. 172 
The following day, beads were removed from precleared chromatin and antibodies-beads 173 
complexes were washed two times in PBS-BSA 5%. ChIP was then carried out for 4h at 4°C 174 
The antibody-chromatin complexes were subsequently washed three times with each buffer 175 
A (50 mM Tris-HCl, pH 7.5, 10 mM EDTA, 5 mM sodium butyrate, 75 mM NaCl), B (50 mM 176 
Tris-HCl, pH 7.5, 10 mM EDTA, 5 mM sodium butyrate, 125 mM NaCl) and C (50 mM Tris-177 
HCl, pH 7.5, 10 mM EDTA, 5 mM sodium butyrate, 175 mM NaCl) to ensure only the fraction 178 
of chromatin linked to the antibodies was retained. Elution was performed in 400 µL of elution 179 
buffer (20 mM Tris-HCl pH 7.5, 50 mM NaCl, 5 mM EDTA, 1% SDS). After a digestion with 180 
proteinase K (100 µg/mL) for 1 hour at 65°C, DNA was obtained from the input and bound 181 
fractions with Nucleospin gel and PCR clean-up (Macherey-Nagel), according to the 182 
manufacturer’s protocol (protocol for samples SDS rich for bound fractions) with a final 183 
elution with 40 µL of water. 184 
 185 
Quantification of immunoprecipitated chromatin 186 
For an initial check of precipitated DNA quality, allelic specificity PCR assays were performed 187 
on all heterozygous samples. The PCR regions incorporated a Single Nucleotide 188 
Polymorphisms (SNPs) to allow both alleles to be discriminated. PCR and direct sequencing 189 
as used interrogate sequence traces, using Sequencher v4.6 (Gene Codes Corporation, MI). 190 




Levels of immunoprecipitated chromatin at each region of interest were determined by 193 
quantitative real-time PCR amplification with the QuantStudioTM 5 Real-Time PCR system 194 
(Applied BiosystemsTM), using the SYBRTM Green PCR Master Mix (Applied) (see 195 
supplemental Table S2). Data were analysed with QuantStudioTM Design & Analysis 196 
Software (v1.3.1). Each PCR was run in triplicate and level of immunoprecipitation was 197 
quantified as a percentage of total input material as follows: % of input = 2(-ΔCt) where ΔCt is 198 
the difference in mean Ct triplicate between the DNA of interest and the DNA of the input. 199 
To overcome the inherent variability of different immunoprecipitations, precipitation levels 200 
obtained at the region of interest were normalized to the level obtained for positive control 201 
intervals. Interrogation of placenta ChIP-seq datasets in the Genome Data viewer function in 202 
the GEO data repository revealed that the promoter of KLF10 was enriched for the 203 
permissive histone marks H3K4me3, H3K4me2 and H3K9ac and was selected as a control 204 
region. For a control of repressed chromatin, we selected a heterochromatic satellite region 205 
on chromosome 4, which is ubiquitously associated with both H3K9me3 and H3K9me2.  206 
 207 
Methylation-sensitive genotyping 208 
Approximately 500 ng of heterozygous placenta DNA was digested with 10 units of HpaII and 209 
BstU1 restriction endonuclease for 6 hours at 37°C. The digested DNA was subject to 210 
ethanol precipitation and resuspended in a final volume of 20 μl TE. Approximately 50 ng of 211 
digested DNA was used in each amplification reaction. The resulting amplicons were 212 
sequenced, and the sequences traces were compared to those obtained for the 213 
corresponding undigested DNA template.  214 
 215 
Statistical analyses 216 
Categorical variables were expressed as numbers (percentages) and compared using the 217 
Chi-2 test or Fisher exact test when appropriate. Continuous variables were expressed as 218 
means ± standard deviations (SD) or medians and interquartile ranges [IQR] and compared 219 
using the Student or Mann-Whitney test, as appropriate. Birth weights were normalized by 220 
10 
 
conversion to z-scores calculated using normal birthweight curves of our population 221 
accounting for gestational age and new-born’s sex [23]. Placental weights were also 222 
converted into z-scores according to gestational age and new-born’s sex [24]. All statistical 223 
analyses were performed with SAS software, version 9.4 (SAS Institute Inc, USA). A two-224 




Confirmation of in-silico histone modifications profiles in term placentas 229 
To ensure the PCR amplified intervals mapping to the imprinted DMRs were enriched for the 230 
histone modification of interest, we performed an in-silico analysis to ensure primer design 231 
coincided with the largest peaks in placenta-derived ChIP-seq datasets (GEO accession 232 
numbers GSM1160199 for H3K4me3; GSM753439 for H3K4me2, GSM818049 for H3K9ac 233 
and GSM1160204 for H3K9me3). Following primer optimization, amplicons of ~120-200bp, 234 
which would allow for amplification of dinucleosome fragments and larger, were used to 235 
quantify the precipitation levels for the three imprinted loci of interest: H19/IGF2 (Figure 2A), 236 
KCNQ1OT1 (Figure 2B) and SNURF (Figure 2C) DMRs.  237 
Subsequently we analysed the allelic precipitation of the ChIP material in the 16 naturally 238 
conceived control samples, since we anticipated that permissive and repressive histone 239 
marks should be on opposite parental alleles at these imprinted DMRs. PCR were performed 240 
using primers that flanked highly informative SNPs and the resulting amplicons sequenced. 241 
In total 9 samples were heterozygous for H19/IGF2 (rs2107425), 9 for KCNQ1OT1 242 
(rs11023840) and 9 for rs4906939 within the SNURF DMR. The allelic precipitation levels 243 
were compared to methylation-sensitive genotyping, which revealed that the permissive 244 
marks were solely on the unmethylated allele and the repressive marks preferentially on the 245 




Comparison between IVF/ICSI and natural conception groups 248 
The two groups were comparable in terms of parental and new-born characteristics (Table 249 
1). As expected, the mean group DNA methylation of H19/IGF2, KCNQ1OT1 and SNURF 250 
DMRs was significantly lower in the IVF/ICSI group (45.1% [43.2-48.9]; 32.8% [31.7-35.7] 251 
and 38.3% [35.5-40.5], respectively) compared to those conceived naturally (53.5% [49.6-252 
59.3], P = 0.004; 39.4% [34.8-41.9], P = 0.001 and 41.2% [38.4-42.1], P = 0.036, 253 
respectively; Table 2, Figure 4A). Relative expression was not different between groups 254 
(Table 2). 255 
Quantitative PCR targeting H19/IGF2 and SNURF DMRs in the H3K9me3 and H3K9me2 256 
precipitated material revealed significantly lower quantities of H3K9me3 and H3K9me2 in the 257 
IVF/ICSI group than in the natural conception group (P = 0.011 and 0.027 for H19/IGF2, 258 
respectively; and P = 0.010 and 0.035 for SNURF, respectively; Figure 4B). There was no 259 
significant difference for either repressive mark at KCNQ1OT1 DMR (Figure 4B). 260 
The quantity of H3K4me2 at H19/IGF2 and KCNQ1OT1 DMRs was significantly higher in the 261 
IVF/ICSI group than in the natural conception group (P = 0.016 and 0.003, respectively; 262 
Figure 4C). There was no significant difference for H3K4me2 for SNURF, or for the other two 263 
permissive marks (H3K4me3, H3K9ac; Figure 4C).  264 
When the 8 conventional IVF cases were compared with the 8 IVF with ICSI, it showed that 265 
there was no methylation difference between both groups (Supplemental Figure 2A). 266 
However, the quantity of H3K9me3 at KCNQ1OT1 DMR was significantly lower in the ICSI 267 
than in the IVF group (P = 0.032; Supplemental Figure 2B), while the quantity of H3K4me2 in 268 
the same interval was significantly higher in the ICSI than in the IVF group (P = 0.003; 269 
Supplemental Figure 2C). There was no significant difference for the other permissive marks 270 
H3K4me3 and H3K9ac, repressive mark H3K9me2, nor for the SNRPN and H19/IGF2 DMRs 271 
(Supplemental Figure 2). 272 
12 
 
One hypothesis that could explain the increased of permissive histone modifications in some 273 
samples was the presence of these marks on the normally repressed allele. To address this, 274 
we focused on the allelic precipitation profiles in IVF/ICSI samples with highest precipitation 275 
levels (>75th percentile) of permissive marks at the H19/IGF2 DMR. Sequencing of samples 276 
heterozygous for SNPs revealed that the normally methylated allele was decorated with 277 
H3K4me2 and H3K9ac (Supplemental Figure 3). However similar experiments targeting the 278 
KCNQ1OT1 and SNURF regions revealed maintained monoallelic precipitation patterns, 279 





These data demonstrate that DNA hypomethylation at imprinted DMRs could be associated 285 
with an increase in permissive histone marks and/or with a decrease in repressive histone 286 
modifications. This is consistent with a more “permissive” chromatin conformation on the 287 
normally repressed allele. However, by focusing on outlier samples with highest precipitation 288 
levels of permissive marks and heterozygous for SNPs, we observed the enrichment of 289 
H3K4 methylation and H3K9 acetylation on the normally repressed and DNA methylated 290 
allele at the H19/IGF2 region. This suggests that some cells within the samples could lose 291 
their allelic methylation and subsequently gained the permissive histone modifications. Single 292 
cell studies, possible incorporating Assay for Transposase-Accessible Chromatin using 293 
sequencing (ATAC-seq) would be required to clarify this observation. In the KCNQ1OT1 and 294 
SNURF regions, i.e. maternally imprinted genes, the monoallelic imprint seemed to be 295 
preserved.  296 
Several studies have addressed the stability of DNA methylation in placenta after IVF. The 297 
first reported lower DNA methylation levels in placentas after IVF than after natural 298 
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pregnancy [25], whilst other observed hypomethylation at the MEST and H19 loci [25-27]. 299 
Our previous work evidenced lower DNA methylation levels of two imprinted loci (H19/IGF2 300 
and KCNQ1OT1) and two transposable elements (LINE-1 and ERVFRD-1) in IVF placentas 301 
while there was not any statistical difference between IVF and controls for SNURF DNA 302 
methylation [18]. However not all studies have shown such clear-cut differences [28]. 303 
Concerning gene expression, higher levels of expression of some IGs such as MEST and 304 
H19 have been demonstrated after IVF [25,26], but other studies found lower expression 305 
levels for IGF2 and H19 [29].  306 
To our knowledge, this study is the first reporting altered post-translational histone 307 
modification abundance in the human placenta after ART. Indeed, most studies focusing on 308 
histone regulation have been conducted in mouse models and mainly in pre-implantation 309 
embryos. For example, a study profiling epigenetic modifications at the Mest and H19 loci in 310 
mouse blastocysts cultured in vitro found an increased abundance of permissive histone 311 
marks and a decrease in repressive histone modifications [21]. The same team confirmed 312 
these trends at the H19/Igf2 region on two cohorts of 2-cells embryos cultured in vitro until 313 
the blastocyst stage or vitrified/thawed and then cultured in vitro until the blastocyst stage 314 
[30]. Similarly, altered methylation of histones and DNA at the H19/Igf2 region has also been 315 
shown in embryonic stem cells derived from mice pre-implantation embryos [31]. 316 
Interestingly, in an IVF cattle model, a higher expression of the imprinted gene PHLDA2 was 317 
associated with an increase in the permissive mark H3K4me2 in its promoter [32]. Overall, 318 
our results are consistent with those reported in these models.  319 
The increased in permissive and decrease of repressive histones marks observed in our 320 
study in hypomethylated samples following ART support the hypothesis that chromatin could 321 
be more permissive to transcription. However, increased expression was evidenced neither 322 
in this study nor in our previous one [18]. Nevertheless, as we worked on term placentas, 323 
plasticity and adaptability of placenta to environment [7] suggest that the altered expression 324 
could occur throughout pregnancy and no longer be visible at birth. This is well demonstrated 325 
by increased Igf2 expression after ART in superovulated mice placenta during gestation but 326 
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no longer visible at birth [33,34] and by the observation that a positive correlation between 327 
placental IGF2 expression and birth weight is only present during the first trimester and not at 328 
term [35]. Indeed, as the placenta undergoes rapid epigenomic changes during gestation, a 329 
placenta collected at birth may not reflect the changes occurring throughout pregnancy [17]. 330 
However, these epigenetic changes occurring during prenatal period, probably participating 331 
in compensation mechanisms [7,18], raise questions about the potential long-term effects of 332 
such modifications on children conceived by ART. As for the origin of these modifications, 333 
recent studies showed that levels of histones mRNA could be different in infertile patients’ 334 
sperm compared to controls [36], and that H3K4me2 could be a molecular marker of sperm 335 
quality [37], which raises questions about potential modifications in histones physiology 336 
related to infertility. Moreover, increase in permissive and decrease in repressive histone 337 
marks at KCNQ1OT1 DMR in ICSI group compared to IVF group suggest that specific ICSI 338 
protocols might influence histone regulation. 339 
A limitation of this study could be the restricted number of IGs and histone marks studied. It 340 
would be interesting to extend analyses to other imprinted DMRs as well as imprinted genes 341 
with unmethylated promoters, regulated by neighbouring DMRs in cis, such as CDKN1C and 342 
PHLDA2 [22]. Furthermore, studying non-imprinted loci associated with early and late 343 
placental development could be revealing. It would also be interesting to decipher the proper 344 




These novel findings highlight that DNA hypomethylation at imprinted DMRs after ART is 349 
linked with increased permissive/decreased repressive histones marks, altogether promoting 350 
an “permissive” conformation of the chromatin. This concomitant change in epigenetic state 351 
at IGs at birth might be an important developmental event as a consequence of ART. To 352 
date, exact causes and consequences of these changes are not known. Better knowledge of 353 
15 
 
the mechanisms at stake could enable to adapt our daily practice in order to reduce the 354 
impact of these changes. 355 
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Figure 1: Flowchart. 
From our precedent study [18], we selected the patients from IVF/ICSI group who presented with below the 5th percentile of percentage methylation for at 
least one of the studied DMRs (H19 DMR, KCNQ1OT1 DMR and SNURF). The 16 selected patients were then matched for 16 controls from the natural 
conception group for parity, new-born’s sex, and gestational age at delivery. 
 
Figure 2: Mapping of histone marks in placenta for each region of interest 
For each region of interest (H19 DMR (A), KCNQ1OT1 DMR (B) and SNURF DMR (C)), we marked in green the sequence amplified by the qRT-PCR ChIP 
primers. To ensure the PCR amplified intervals mapping to the imprinted DMRs were enriched for the histone modification of interest, we performed an in-
silico analysis to ensure primer design coincided with the largest peaks in placenta-derived ChIP-seq datasets. We used the Gene Expression Omnibus (GEO) 
application, available at https://www.ncbi.nlm.nih.gov/geo/. The GEO accession numbers for H3K4me3, H3K4me2, H3K9ac, and H3K9me3 were 
GSM1160199 (Histone H3K4me3 ChIP-Seq of Fetal Placenta), GSM753439 (ChIP-Seq Analysis of H3K4me2 in BMP4 Trophoblast Cells), GSM818049 (ChIP-Seq 
Analysis of H3K9ac in BMP4 Trophoblast Cells) and GSM1160204 (Histone H3K9me3 ChIP-Seq of Fetal Placenta), respectively. In parallel, normalized 
precipitation levels obtained in the 16 control samples of our cohort are displayed for each studied region. Precipitation levels of permissive marks 
H3K4me3, H3K4me2 and H3K9ac were normalized on precipitation levels of the KLF10 gene whereas repressive marks H3K9me3 and H3K9me2 were 




Figure 3: Histone post-translational modifications are imprinted in the placenta 
For each region of interest, an informative SNP was selected, the control DNA was genotyped, and heterozygous samples were studied. DNA was digested 
by HpaII and BstUI before sequencing to evidence the methylated allele. Then the ChIP products were also sequenced to assess which allele was the most 
represented in either permissive or repressive marks. It appears that the unmethylated allele is mostly represented in the permissive marks H3K4me3, 
H3K4me2 and H3K9ac. On the contrary, the methylated allele is mostly represented in the repressive marks H3K9me3 and H3K9me2. Thus methylated 
regions are associated with repressive histone marks whereas unmethylated regions are associated with permissive histone marks. 
 
Figure 4: Comparisons between IVF/ICSI group and controls. 
DNA methylation levels were lower in the IVF/ICSI group than in the natural conception group (A), some repressive and permissive marks normalized 
precipitation levels were lower and higher, respectively, in the IVF/ICSI group compared to the natural conception group (B and C, respectively). 
Each box represents the interquartile range (IQR). Lines inside the boxes are the median. Whiskers represent the 10th and 90th percentiles. Crosses represent 
the mean. For the histone marks profiling, the figures present the ratio between the % of input obtained at the region of interest and the % of input 





Table 1. Population characteristics 
  
Natural Conception (n = 16) IVF/ICSI (n = 16) P 
Maternal characteristics     
Age (years) 28.5 +/- 4.2 31.3 +/- 6.3 0.137  
Pre-pregnancy parity 0 [0 - 0.5] 0 [0 - 0.5] 0.980  
Tobacco Smoking 2 (1.3%) 1 (6.3%) 1  
Pre-pregnancy BMI (kg/m2) 21.7 +/- 2.8 24.6 +/- 4.8 0.050 
Paternal characteristics     
Age (years) 30.7 +/- 5.8 32.8 +/- 5.5 0.306  
Tobacco smoking 3 (1.9%) 5 (3.1%) 0.685 
New-born characteristics     
Term (weeks of gestation) 39.7 +/- 1.1 38.9 +/- 2.1 0.194  
Birth weight (grams) 3310.9 +/- 461.6 3184.1 +/- 593.7 0.505  
z-score of birth weight 0.06 +/- 1.13 0.10 +/- 1.23 0.930  
Placenta weight (grams) 483.4 +/- 109.1 517.8 +/- 135.1 0.435  
z-score of placenta weight -1.39 +/- 0.82 -1.02 +/- 0.93 0.235  
Sex ratio M/F [95 % CI] 0.60 [0.43 - 0.77] 0.60 [0.43 - 0.77] 1 










Results are displayed as median [interquartile range]. P-values 
are the result of Student or Mann-Whitney test, as recommended 










Natural conception IVF/ICSI P Natural conception IVF/ICSI P 
Imprinted genes       
H19/IGF2 53.54 [49.59-59.29] 45.09 [43.16-48.94] 0.004 228.34 [186.14-350.50] 301.83 [173.01-506.40] 0.395  
KCNQ1OT1 39.38 [34.76-41.94] 32.79 [31.70-35.73] 0.001 0.06 [0.05-0.11] 0.06 [0.04-0.23] 0.594  




















































































Table S1: Primers for sequencing 
Region Data base Reference 
Sequence Number 
Nucleotide position Primers (sequencing primer in bold) 
Product 
Reaction temperature 
Imprinted  genes     
H19/IGF2: IG-DMR UCSC hg38: chr11:1,997,582-2,003,510 
F: GGGCTGTCCTTAGACGGAGTC 409 pb 
R: GTATTTCTGGAGGCTTCTCC 56°C 
KCNQ1OT1: TSS- DMR UCSC hg38 : chr11:2,698,718-2,701,029 
F: GATGCCACCCGGGCTCAGATTGG 216  pb 
R: ACCCCGGGGTGGTGAACACATCA 56°C 
SNURF: TSS-DMR UCSC hg38 : chr15:24,954,857-24,956,829 
F: ACTGCGCCACAACCGGAAAGGAA 320 pb 
R: GTAGAGCCGCCAGTGGGGAGGG 56°C 
 
Bioline products were used for the PCR mix as follows: water 11.55 µL, 5M betaine  7.5 µL, 10xNH4 Reaction Buffer 2.5 µL, 50 mM MgCl2 0.75 µL, 2 mM dNTP 0.5 µL, BIOTAQ DNA polymerase 5U/µL 0.2 µL, with 1 µL 
DNA and 2 ng/µL of each primer, for a final volume of 25 µL. Amplification was performed with the following conditions: 5 min denaturation phase at 96°C, followed by 40 cycles of three steps: 30 s denaturation at 




Table S2: Primers for qRT-PCR ChIP 
Region Data base Reference 
Sequence Number 
Nucleotide position Primers 
Product 
Reaction temperature 
Housekeeping genes     
KLF10 Ensembl Ensembl ENSG00000155090 hg 38: chr 8:102,648,779-102,655,902 reverse strand 
F: GACAAGACCAGGCGAGGAAG 89 pb 
R: GCCAACCATGCTCAACTTCG 60°C 
SATα chr4 NCBI Alexiadis et al., 2017 M38467 
F: CTGCACTACCTGAAGAGGAC 139 pb 
R: GATGGTTCAACACTCTTACA 60°C 
Imprinted  genes     
H19/IGF2: IG-DMR UCSC hg38: chr11:1,997,582-2,003,510 
F: AGCTGTGCTCTGGGATAGATG 60 pb 
R: ATGATCACAGTGTGTTCCACC 60°C 
KCNQ1OT1: TSS- DMR UCSC hg38 : chr11:2,698,718-2,701,029 
F: ATTTCCGACTCCGGTCCCAA 94 pb 
R: CATCGTGGTTCTGAGTCCGC 60°C 
SNURF: TSS-DMR UCSC hg38 : chr15:24,954,857-24,956,829 
F: CTGTGCTACTGCCCCTTCTG 68 pb 
R: GGAGTGACTAAGGGACGCTGAATG 60°C 
 
4.5 µL 2X SYBRTM Green PCR Master Mix (Applied) was used with 0.1 µL primers (0.1 µg/µL), 0.4 µL water and 5 µL DNA (diluted 1/40), for a final volume of 10 µL. Amplification was performed in triplicate using QuantStudioTM 5 Real-Time PCR system 





Supplemental Figure 1: Nucleosome ladder 
100 µL of each fraction of chromatin S1 and S2 were cleaned and migrated on an agarose gel. Then the 
gel was immersed in a midori green bath during 2 hours. S1 chromatin fraction was mostly composed 






Supplemental Figure 2: Comparisons between conventional IVF and ICSI. 
DNA methylation levels were not significantly different between both groups (A), some repressive 
and permissive marks normalized precipitation levels were lower and higher, respectively, in the ICSI 
group compared to IVF group (B and C, respectively). 
Each box represents the interquartile range (IQR). Lines inside the boxes are the median. Whiskers 
represent the 10th and 90th percentiles. Crosses represent the mean. For the histone marks profiling, 
the figures present the ratio between the % of input obtained at the region of interest and the % of 
input obtained at the control region. IVF: In Vitro Fertilization, ICSI: IVF with Intra Cytoplasmic Sperm 








Supplemental Figure 3: Analysis of the outliers in the H19/IGF2 region 
A: Placental DNA methylation of IVF/ICSI group (in purple) vs. natural conception group (in green). Bars 
represent the median with the interquartile range. The outliers studied are marked with red dots. 
PL163 represents the control placenta at the SNP rs2107425 of this region. Sequencing of cDNA 
(genotyping), DNA digested with HpaII and input chromatin for ChIP and chromatin precipitated with 
permissive histone marks H3K4me3, H3K4me2 and H3K9ac are displayed. 
B: Precipitation levels of H3K4me2 normalized on KLF10, with the 3 outliers studied marked with red 
dots (PL1, 27 and 155). Sequencing of the 3 outliers for controls (genotype, HpaII and input) and for 
H3K4me2 
C: Precipitation levels of H3K9ac normalized on KLF10, with the 2 outliers studied marked with red dots 





Supplemental Figure 4: Analysis of the outliers in the KCNQ1OT1 region 
A: Placental DNA methylation of IVF/ICSI group (in purple) vs. natural conception group (in green). Bars 
represent the median with the interquartile range. The outliers studied are marked with red dots. 
PL166 represents the control placenta at the SNP rs11023840 of this region. Sequencing of cDNA 
(genotyping), DNA digested with HpaII and BstUI and input chromatin for ChIP and chromatin 
precipitated with permissive histone marks H3K4me3, H3K4me2 and H3K9ac are displayed. 
B: Precipitation levels of H3K4me3 normalized on KLF10, with the outlier studied marked with red dot 
(PL163). Sequencing of the outlier for controls (genotype, HpaII + BstUI and input) and for H3K4me3 
C: Precipitation levels of H3K4me2 normalized on KLF10, with the outlier studied marked with red dot 
(PL1). Sequencing of the outlier for controls (genotype, HpaII + BstUI and input) and for H3K4me2 
D: Precipitation levels of H3K9ac normalized on KLF10, with the outlier studied marked with red dot 





Supplemental Figure 5: Analysis of the outliers in the SNURF region 
A: Placental DNA methylation of IVF/ICSI group (in purple) vs. natural conception group (in green). Bars 
represent the median with the interquartile range. The outliers studied are marked with red dots. PL67 
represents the control placenta at the SNP rs4906939 of this region. Sequencing of cDNA (genotyping), 
DNA digested with HpaII and BstUI and input chromatin for ChIP and chromatin precipitated with 
permissive histone marks H3K4me3, H3K4me2 and H3K9ac are displayed. 
B: Precipitation levels of H3K4me3 normalized on KLF10, with the outliers studied marked with red 
dots (PL27 and 77). Sequencing of the outliers for controls (genotype, HpaII + BstUI and input) and for 
H3K4me3 
C: Precipitation levels of H3K4me2 normalized on KLF10, with the outlier studied marked with red dot 
(PL1). Sequencing of the outlier for controls (genotype, HpaII + BstUI and input) and for H3K4me2 
